Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice

IL-21 and CD40L Synergistically Promote Plasma Cell Differentiation through Upregulation of Blimp-1 in Human B Cells

(2013) B. B. Ding et al.   JOURNAL OF IMMUNOLOGY

The Cellular Source and Target of IL-21 in K/BxN Autoimmune Arthritis

(2013) K. E. Block et al.   JOURNAL OF IMMUNOLOGY

STAT-3 Activation by Differential Cytokines Is Critical for Human In Vivo-Generated Plasma Cell Survival and Ig Secretion

(2013) B. Rodriguez-Bayona et al.   JOURNAL OF IMMUNOLOGY

Interleukin-21 Is a Critical Cytokine for the Generation of Virus-Specific Long-Lived Plasma Cells

(2013) M. A. U. Rasheed et al.   JOURNAL OF VIROLOGY

Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus

(2013) Jie Luo et al.   MOLECULAR IMMUNOLOGY

Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus

(2013) Ashwaq AlE’ed et al.   RHEUMATOLOGY INTERNATIONAL

Blimp-1 siRNA inhibits B cell differentiation and prevents the development of lupus in mice

(2012) Zhongqi Zhou et al.   HUMAN IMMUNOLOGY

Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: Implications for the treatment of autoimmunity

(2012) Imtiaz M. Mumtaz et al.   JOURNAL OF AUTOIMMUNITY

CD69 Regulates Type I IFN-Induced Tolerogenic Signals to Mucosal CD4 T Cells That Attenuate Their Colitogenic Potential

(2012) K. Radulovic et al.   JOURNAL OF IMMUNOLOGY

BLIMP-1 and STAT3 Counterregulate MicroRNA-21 during Plasma Cell Differentiation

(2012) N. A. Barnes et al.   JOURNAL OF IMMUNOLOGY

Molecular Characterization of Circulating Plasma Cells in Patients with Active Systemic Lupus Erythematosus

(2012) Patricia L. Lugar et al.   PLoS One

A B cell explanation for autoimmune disease: the forbidden clone returns

(2012) Fiona McQueen   POSTGRADUATE MEDICAL JOURNAL

B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells

(2011) Sau K. Lee et al.   JOURNAL OF EXPERIMENTAL MEDICINE

B Cell Signature during Inactive Systemic Lupus Is Heterogeneous: Toward a Biological Dissection of Lupus

(2011) Jean-Claude Garaud et al.   PLoS One

B Cell-Targeted Therapies for Systemic Lupus Erythematosus

(2010) R. John Looney   DRUGS

B-lymphocyte effector functions in health and disease

(2010) David J. DiLillo et al.   IMMUNOLOGIC RESEARCH

Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus

(2010) Jing Li et al.   MOLECULAR BIOLOGY REPORTS

B-Cell-Targeted Therapy for Systemic Lupus Erythematosus

(2009) Changhai Ding et al.   BIODRUGS

IL-21 and IL-10 have redundant roles but differential capacities at different stages of plasma cell generation from human germinal center B cells

(2009) Sun-Ok Yoon et al.   JOURNAL OF LEUKOCYTE BIOLOGY

A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus

(2009) Vesela Gateva et al.   NATURE GENETICS

A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice

(2009) J. A. Bubier et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Anti-Sm B cell tolerance and tolerance loss in systemic lupus erythematosus

(2008) Stephen H. Clarke   IMMUNOLOGIC RESEARCH

B-Cell-Directed Therapies in Systemic Lupus Erythematosus

(2008) Arlene T. Tieng et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM